About
Basic Data Updated:
7 days agoCipla Limited is a company that is involved in the production of formulations and active pharmaceutical ingredients (APIs). The product portfolio of CL includes mexacrip, injection vials, pharmaceutical injectables, and tablets. The company, which was incorporated in 1935, has its registered office situated in Mumbai, Maharashtra.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
Products or Services related to Cipla Limited
Financials of Cipla Limited
Cipla Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 4.27% increase. The company also saw a slight improvement in profitability, with a 6.48% increase in profit. The company's net worth Soared by an impressive increase of 14.51%.
Enhance accessibility to Cipla's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Cipla's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Cipla Limited
Unlock and access historical data on people associated with Cipla, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
- Umang Vohra Managing Director
Appointment Date: 01-Sep-2016
Status: Current
MC
Mr Chopra Company SecretaryAppointment Date: 09-Feb-2017
Status: Current
AA
Ashish Adukia CFOAppointment Date: 16-Aug-2022
Status: Current
Board Members(10)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
The Hongkong And Shanghai Banking Corporation Limited (Lead Charge Holder) Creation Date: 17 Apr 1986 | ₹68.50 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cipla, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cipla's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Recent activity within the organization
Annual General Meeting
Cipla Limited last Annual general meeting of members was held on 10 Aug 2023 as per latest MCA records.
10 Aug 2023Balance Sheet
Cipla Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Director Appointment
Mandar Purushottam Vaidya was appointed as a Director was appointed as a Director on 29 Jul 2022 & has been associated with this company since 1 year 9 months .
29 Jul 2022Director Appointment
Ramesh Prathivadibhayankara Rajagopalan was appointed as a Director was appointed as a Director on 01 Jul 2021 & has been associated with this company since 2 years 10 months .
01 Jul 2021Director Appointment
Robert Stewart was appointed as a Director was appointed as a Director on 14 May 2021 & has been associated with this company since 2 years 11 months .
14 May 2021
Recent News, Updates & Announcement
- Cipla Raises Stake In Digital Tech Startup GoApptiv To 2299 For INR 42 Cr.
StartupNews 02 Feb 2024
- Cipla aims to grow respiratory leadership in the US files Symbicort and another generic inhaler.
The New Indian Express 29 Jan 2024
- Cipla Q3 FY24 Results Live Profit Rises by 3183 YoY Mint.
Cipla Q3 FY24 Results Live Revenue Increased by 1366 YoY Profit Increased by 3183 YoY.
mint 25 Jan 2024
- Ciplas EU arm Kemwell Biopharma to establish JV company in USA.
Moneycontrol 06 Jan 2024
- Cipla to sell Croatian subsidiary to PharmaS.
VCCircle 01 Dec 2017
Frequently asked questions
What is the Incorporation or founding date of Cipla Limited?